Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients and improved sales in international markets.

The consumer goods giant reiterated its full-year guidance after underlying sales grew more than expected in the third quarter as shoppers welcomed easing price hikes and began buying more of the company’s branded products.

Unilever (NYSE:UL) gained 2.8% in premarket trade, after the consumer goods company's Q3 underlying sales growth came in better than expected. UL reported underlying sales growth of 4.5% in the third quarter,

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients.